Trials / Completed
CompletedNCT02107885
Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
A Phase 1, Double-blind, Randomized, Placebo-controlled Single Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DS-1971a in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a randomised, double-blind, placebo-controlled and ascending single dose study. It is hypothesised that single oral doses of DS-1971a within the planned dose range will be safe and well tolerated by healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DS-1971 | 6 subjects in each group will receive DS-1971. |
| DRUG | placebo | 2 subjects in each group will receive placebo. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2014-04-08
- Last updated
- 2018-12-24
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02107885. Inclusion in this directory is not an endorsement.